Activation of p38 mitogen-activated protein kinase and c-Jun NH2- terminal kinase by double-stranded RNA and encephalomyocarditis virus: Involvement of RNase L, protein kinase R, and alternative pathways

Molecular and Cellular Biology

Volumn 20, Issue 2, 2000, Pages 617-627

  Iordanov, Mihail S ^a   Paranjape, Jayashree M ^b   Zhou, Aimin ^b   Wong, John ^a   Williams, Bryan R G ^b   Meurs, Eliane F ^c   Silverman, Robert H ^b   Magun, Bruce E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DOUBLE STRANDED RNA; MITOGEN ACTIVATED PROTEIN KINASE; RIBONUCLEASE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVATION; FIBROBLAST; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA CLEAVAGE; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

ANIMALS; CELL LINE; EIF-2 KINASE; ENCEPHALOMYOCARDITIS VIRUS; ENDORIBONUCLEASES; ENZYME ACTIVATION; FIBROBLASTS; GENE DELETION; HUMANS; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; RATS; REPRESSOR PROTEINS; RNA, DOUBLE-STRANDED; RNA, RIBOSOMAL, 28S;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; MAMMALIA; PICORNAVIRIDAE;

EID: 0033970937     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.2.617-627.2000     Document Type: Article

References (67)

1. Baldassare, J. J., Y. Bi, and C. J. Bellone. 1999. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162:5367-5373.
2. Beyaert, R., A. Cuenda, W. Vanden Berghe, S. Plaisance, J. C. Lee, G. Haegeman, P. Cohen, and W. Fiers. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBo J. 15:1914-1923.
3. Brimacombe, R. 1995. The structure of ribosomal RNA: a three-dimensional jigsaw puzzle. Eur. J. Biochem. 230:365-383.
4. Cavigelli, M., W. W. Li, A. Lin, B. Su, K. Yoshioka, and M. Karin. 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBo J. 15:6269-6279.
5. Chebath, J., P. Benech, A. Hovanessian, J. Galabru, and M. Revel. 1987. Four different forms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262:3852-3857.
6. Chen, C. Y., F. Del Gatto-Konczak, Z. Wu, and M. Karin. 1998. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280:1945-1949.
7. Chen, Y. R., X. Wang, D. Templeton, R. J. Davis, and T. H. Tan. 1496. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:31929-31936.
8. Clemens, M. J. 1997. PKR - a protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell Biol. 29:945-949.
9. Clemens, M. J. 1994. Regulation of eukaryotic protein synthesis by protein kinases that phosphorylate initiation factor eIF-2. Mol. Biol. Rep. 19:201-210.
10. Clemens, M. J., and U. A. Bommer. 1999. Translational control: the cancer connection. Int. J. Biochem. Cell Biol. 31:1-23.
11. Clemens, M. J., and A. Elia. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:503-524.
12. Davis, R. J. 1999. Signal transduction by the c-Jun N-terminal kinase. Biochem. Soc. Symp. 64:1-12.
13. Deijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685. (Erratum. 269:17.)
14. Dube, P., G. Bacher, H. Stark, F. Mueller, F. Zemlin, M. van Heel, and R. Brimacombe. 1998. Correlation of the expansion segments in mammalian rRNA with the fine structure of the 80 S ribosome: a cryoelectron microscopic reconstruction of the rabbit reticulocyte ribosome at 21 A resolution. J. Mol. Biol. 279:403-421.
15. Galcheva-Gargova, Z., B. Derijard, I. H. Wu, and R. J. Davis. 1994. An osmosensing signal transduction pathway in mammalian cells. Science 265: 806-808.
16. Gale, M., Jr., and M. G. Katze. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:29-46.
17. Gangemi, J. D., A. Matter, B. Poncioni, and H. K. Hochkeppel. 1989. Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections. J. Interferon Res. 9:275-283.
18. Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211-218.
19. Hambleton, J., S. L. Weinstein, L. Lem, and A. L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 93:2774-2778.
20. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
21. Han, J., J. D. Lee, Y. Jiang, Z. Li, L. Feng, and R. J. Ulevitch. 1996. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 271:2886-2891.
22. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135-2148.
23. Iordanov, M., K. Bender, T. Ade, W. Schmid, C. Sachsenmaier, K. Engel, M. Gaestel, H. J. Rahmsdorf, and P. Herrlich. 1997. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBo J. 16:1009-1022.
24. 2-terminal kinase I, and p38/HOG1 by palytoxin. J. Biol. Chem. 273:3528-3534.
25. Iordanov, M. S., D. Pribnow, J. L. Magun, T. H. Dinh, J. A. Pearson, S. L. Chen, and B. E. Magun. 1997. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28S rRNA. Mol. Cell. Biol. 17:3373-3381.
26. Iordanov, M. S., D. Pribnow, J. L. Magun, T. H. Dinh, J. A. Pearson, and B. E. Magun. 1998. Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells. J. Biol. Chem. 273:15794-15803.
27. Ip, Y. T., and R. J. Davis. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell Biol. 10:205-219.
28. Iwasaki, A., A. Matsumori, T. Yamada, T. Shioi, W. Wang, K. Ono, R. Nishio, M. Okada, and S. Sasayama. 1999. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. J. Am. Coll. Cardiol. 33:1400-1407.
29. Jackson, J. R., B. Bolognese, L. Hillegass, S. Kassis, J. Adams, D. E. Griswold, and J. D. Winkler. 1998. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J. Pharmacol. Exp. Ther. 284:687-692.
30. Jagus, R., B. Joshi, and G. N. Barber. 1999. PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 31:123-138.
31. Kasibhatla, S., T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D. R. Green. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol. Cell 1:543-551.
32. Kerr, I. M., and R. E. Brown. 1978. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75:256-260.
33. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
34. Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H.-D. Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1:94-97.
35. Koyama, A. H., T. Arakawa, and A. Adachi. 1998. Acceleration of virus-induced apoptosis by tumor necrosis factor. FEBS Lett. 426:179-182.
36. Krause, A., H. Holtmann, S. Eickemeier, R. Winzen, M. Szamel, K. Resch, J. Saklatvala, and M. Kracht. 1998. Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J. Biol. Chem. 273:23681-23689.
37. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
38. Le-Niculescu, H., E. Bonfoco, Y. Kasuya, F. X. Claret, D. R. Green, and M. Karin. 1999. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19:751-763.
39. Levin, D., and I. M. London. 1978. Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc. Natl. Acad. Sci. USA 75:1121-1125.
40. Liu, Y., M. Gorospe, C. Yang, and N. J. Holbrook. 1995. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270:8377-8380.
41. Meriin, A. B., J. A. Yaglom, V. L. Gabai, L. Zon, S. Ganiatsas, D. D. Mosser, L. Zon, and M. Y. Sherman. 1999. Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled hy HSP72. Mol. Cell. Biol. 19:2547-2555. (Erratum, 19:5235.)
42. Meurs, E., K. Chong, J. Galabru, N. S. Thomas, I. M. Kerr, B. R. Williams, and A. G. Hovanessian. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390.
43. Miyazawa, K., A. Mori, H. Miyata, M. Akahane, Y. Ajisawa, and H. Okudaira. 1998. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273:24832-24838.
44. Nagata, Y., and K. Todokoro. 1999. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94:853-863.
45. Pandey, P., J. Raingeaud, M. Kaneki, R. Weichselbaum, R. J. Davis, U. Kufe, and S. Kharbanda. 1996. Activation of p38 mitogen-activated protein kinase by c-Ab1-dependent and -independent mechanisms. J. Biol. Chem. 271: 23775-23779.
46. Player, M. R., and P. F. Torrence. 1998. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 78:55-113.
47. Proud, C. G. 1995. PKR: a new name and new roles. Trends Biochem. Sci. 20:241-246.
48. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420-7426.
49. Rincon, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. S. Su, L. A. Penix, R. J. Davis, and R. A. Flavell. 1998. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBo J. 17:2817-2829.
50. Schaeffer, H. J., and M. J. Weber. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:2435-2444.
51. Shifrin, V. I., and P. Anderson. 1999. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. Biol. Chem. 274: 13985-13992.
52. Shioi, T., A. Matsumori, and S. Sasayama. 1996. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94: 2930-2939.
53. Silverman, R. H. 1997. 2-5A dependent RNase L: a regulated endoribonuclease in the interferon system, p. 515-551. In J. F. Riordan and G. D'Alessio (ed.), Ribonucleases: structures and functions. Academic Press, Inc., San Diego, Calif.
54. Silverman, R. H., P. J. Cayley, M. Knight, C. S. Gilbert, and I. M. Kerr. 1982. Control of the ppp(a2′p)nA system in HeLa cells. Effects of interferon and virus infection. Eur. J. Biochem. 124:131-138.
55. Silverman, R. H., J. J. Skehel, T. C. James, D. H. Wreschner, and I. M. Kerr. 1983. rRNA cleavage as an index of ppp(A2′p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J. Virol. 46:1051-1055.
56. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
57. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727-736.
58. Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493.
59. Tournier, C., A. J. Whitmarsh, J. Cavanagh, T. Barrett, and R. J. Davis. 1997. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA 94:7337-7342.
60. Westwick, J. K., C. Weitzel, A. Minden, M. Karin, and D. A. Brenner. 1994. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269:26396-26401.
61. Williams, B. R. 1997. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 25:509-513.
62. Wreschner, D. H., T. C. James, R. H. Silverman, and I. M. Kerr. 1981. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res. 9:1571-1581.
63. Wysk, M., D. D. Yang, H. T. Lu, R. A. Flavell, and R. J. Davis. 1999. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96:3763-3768.
64. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
65. Zhou, A., B. A. Hassel, and R. H. Silverman. 1993. Expression cloning of 2-5A-dependent RNase: a uniquely regulated mediator of interferon action. Cell 72:753-765.
66. Zhou, A., J. M. Paranjape, S. D. Der, B. R. Williams, and R. H. Silverman. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435-440.
67. Zhou, A., J. M. Paranjape, B. A. Hassel, H. Nie, S. Shah, B. Galinski, and R. H. Silverman. 1998. Impact of RNase L overexpression on viral and cellular growth and death. J. Interferon Cytokine Res. 18:953-961.